Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart monitor improve blood sugar control for dialysis patients?

NCT ID NCT06641765

Ongoing Disease control Sponsor: Bo Feldt-Rasmussen Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a continuous glucose monitor (CGM) helps dialysis patients with type 1 or type 2 diabetes control their blood sugar better than standard finger-prick tests. 96 participants will be split into three groups: standard care, intermittent CGM use, or continuous CGM use for 9 months. The goal is to see if CGM increases the time blood sugar stays in a healthy range.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous Glucose Monitor (Dexcom G7)
What this could lead to
If successful, this could show that CGM helps dialysis patients better manage their blood sugar and reduce complications.
What could go wrong
This is a relatively small, early-stage study (96 participants) and may not prove long-term benefits. The device may not be accurate or practical for all dialysis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypoglycemia type 1 diabetes mellitus type 1 diabetes mellitus 1 type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTINUOUS GLUCOSE MONITORING DIABETES MELLITUS, TYPE 1 DIABETES MELLITUS, TYPE 2 HAEMODIALYSIS PERITONEAL DIALYSIS

Contacts and locations

Locations

  • Herlev Hospital

    Herlev, 2730, Denmark

  • Holbæk Sygehus

    Holbæk, 4300, Denmark

  • North Zealand Hospital, Hillerød

    Hillerød, 3400, Denmark

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Zealand University Hospital

    Roskilde, 4000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.